Cytek Biosciences, Inc. director Richard Chin reports a transaction involving 6,107 shares of common stock, reflecting the company's ongoing growth strategy.
| Name | Cytek Biosciences, Inc. |
|---|---|
| CIK | 0001831915 |
| Tickers | CTKB |
| Exchanges | Nasdaq |
| Entity type | operating |
| Category | Accelerated filer |
| SIC | 3826 Laboratory Analytical Instruments |
| EIN | 472547526 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | DE DE |
| Phone | (877) 922-9835 |
| Website | — |
| Investor website | — |
| Owner org | 08 Industrial Applications and Services |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
Cytek Biosciences, Inc. director Richard Chin reports a transaction involving 6,107 shares of common stock, reflecting the company's ongoing growth strategy.
Cytek Biosciences, Inc. director Michael Holder disclosed a transaction involving 2,181 shares of common stock, indicating ongoing confidence in the company.
Cytek Biosciences, Inc. director Glenn P. Muir acquires 4,629 shares, signaling commitment to the company's growth in laboratory analytical instruments.
Boston Partners has increased its stake in Cytek Biosciences, holding over 6% of the company's shares, indicating growing interest in the sector.
Cytek Biosciences, Inc. announces third-quarter results, highlighting revenue growth and strong demand in the laboratory analytical instruments sector.
Cytek Biosciences updates its beneficial ownership report, revealing significant stakes held by Millennium Management and Integrated Core Strategies.
472 filing rows loaded from submissions recent.
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-20 | 4 | xslF345X06/form4-11202026_091129.xml | 0001181190-26-000008 | 7662 | ||||||
| 2026-11-20 | 4 | xslF345X06/form4-11202026_091131.xml | 0001515140-26-000006 | 7706 | ||||||
| 2026-11-20 | 4 | xslF345X06/form4-11202026_091110.xml | 0001874041-26-000010 | 26295 | ||||||
| 2026-11-20 | 4 | xslF345X06/form4-11202026_091147.xml | 0001337252-26-000006 | 7693 | ||||||
| 2026-11-20 | 4 | xslF345X06/form4-11202026_091126.xml | 0001878824-26-000005 | 20745 | ||||||
| 2026-11-20 | 4 | xslF345X06/form4-11202026_091103.xml | 0001872873-26-000007 | 26292 | ||||||
| 2026-11-13 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001386060-26-000063 | 005-92754 | 261550287 | 34 | 7666 | |||
| 2026-11-12 | 4 | xslF345X06/form4-11132026_011110.xml | 0002141966-26-000004 | 6277 | ||||||
| 2026-11-04 | 10-Q | 10-Q | 0001628280-26-070259 | 001-40632 | 261523581 | 34 | 10234488 | 1 | 1 | |
| 2026-11-04 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-447300 | 001-40632 | 261522449 | 34 | 280269 | 1 | 1 |
| 2026-11-03 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001104659-26-122222 | 005-92754 | 261519331 | 34 | 19469 | |||
| 2026-09-29 | 8-K | 8-K | 5.03,9.01 | 0001193125-26-407330 | 001-40632 | 261423708 | 34 | 347010 | 1 | 1 |
| 2026-09-02 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-008998 | 001-40632 | 261354911 | 33 | 4723 | |||
| 2026-08-24 | 8-K | 8-K | 7.01,8.01,9.01 | 0001193125-26-361705 | 001-40632 | 261306261 | 34 | 158533 | 1 | 1 |
| 2026-08-20 | 4 | xslF345X06/form4-08202026_080812.xml | 0001872873-26-000006 | 26304 | ||||||
| 2026-08-20 | 4 | xslF345X06/form4-08202026_080854.xml | 0001878824-26-000004 | 20740 | ||||||
| 2026-08-20 | 4 | xslF345X06/form4-08202026_080825.xml | 0001181190-26-000007 | 7659 | ||||||
| 2026-08-20 | 4 | xslF345X06/form4-08202026_080828.xml | 0001515140-26-000005 | 7703 | ||||||
| 2026-08-20 | 4 | xslF345X06/form4-08202026_080801.xml | 0001337252-26-000005 | 7690 | ||||||
| 2026-08-20 | 4 | xslF345X06/form4-08202026_080851.xml | 0001874041-26-000009 | 26291 | ||||||
| 2026-08-12 | 4 | xslF345X06/form4-08122026_100817.xml | 0002141966-26-000002 | 8711 | ||||||
| 2026-08-06 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001104659-26-092212 | 005-92754 | 261250938 | 34 | 18242 | |||
| 2026-08-05 | 10-Q | 10-Q | 0001628280-26-053496 | 001-40632 | 261244673 | 34 | 9868569 | 1 | 1 | |
| 2026-08-05 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-335212 | 001-40632 | 261243944 | 34 | 280464 | 1 | 1 |
| 2026-08-04 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001386060-26-000050 | 005-92754 | 261240214 | 34 | 7545 | |||
| 2026-07-15 | 8-K | 8-K | 5.02 | 0001193125-26-304789 | 001-40632 | 261177553 | 34 | 137726 | 1 | 1 |
| 2026-07-08 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0002012383-26-001934 | 005-92754 | 261161249 | 34 | 11012 | |||
| 2026-06-30 | 3 | xslF345X06/form3-07012026_010722.xml | 0002141966-26-000001 | 10264 | ||||||
| 2026-06-25 | 8-K | 8-K | 5.02 | 0001193125-26-282871 | 001-40632 | 261122385 | 34 | 133235 | 1 | 1 |
| 2026-06-16 | 4 | xslF345X06/form4-06162026_080659.xml | 0001874041-26-000007 | 4821 | ||||||
| 2026-06-16 | 8-K | 8-K | 5.07 | 0001193125-26-272582 | 001-40632 | 261094643 | 34 | 144329 | 1 | 1 |
| 2026-06-12 | 4 | xslF345X06/form4-06122026_110614.xml | 0001873083-26-000001 | 7247 | ||||||
| 2026-06-12 | 4 | xslF345X06/form4-06122026_110625.xml | 0001181190-26-000005 | 8454 | ||||||
| 2026-06-12 | 3 | xslF345X06/form3-06122026_110630.xml | 0001181190-26-000004 | 9410 | ||||||
| 2026-06-12 | 4 | xslF345X06/form4-06122026_110652.xml | 0001337252-26-000003 | 8201 | ||||||
| 2026-06-12 | 4 | xslF345X06/form4-06122026_110652.xml | 0001902959-26-000001 | 11906 | ||||||
| 2026-06-12 | 4 | xslF345X06/form4-06122026_110651.xml | 0001221786-26-000001 | 11906 | ||||||
| 2026-06-12 | 4 | xslF345X06/form4-06122026_110655.xml | 0001515140-26-000003 | 11906 | ||||||
| 2026-06-02 | 8-K | 8-K | 5.02 | 0001193125-26-253538 | 001-40632 | 261056236 | 34 | 132298 | 1 | 1 |
| 2026-06-01 | SD | SD | 0001193125-26-251413 | 001-40632 | 261050776 | 34 | 23131 | |||
| 2026-05-20 | 4 | xslF345X06/form4-05202026_100527.xml | 0001515140-26-000002 | 7686 | ||||||
| 2026-05-20 | 4 | xslF345X06/form4-05202026_090523.xml | 0001337252-26-000002 | 7673 | ||||||
| 2026-05-20 | 4 | xslF345X06/form4-05202026_090518.xml | 0001874041-26-000005 | 26347 | ||||||
| 2026-05-20 | 4 | xslF345X06/form4-05202026_090503.xml | 0001991396-26-000002 | 26363 | ||||||
| 2026-05-20 | 4 | xslF345X06/form4-05202026_090527.xml | 0001872873-26-000004 | 26445 | ||||||
| 2026-05-20 | 4 | xslF345X06/form4-05202026_090502.xml | 0001878824-26-000002 | 20781 | ||||||
| 2026-05-20 | 4 | xslF345X06/form4-05202026_090558.xml | 0001873091-26-000004 | 26332 | ||||||
| 2026-05-18 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001104659-26-063322 | 005-92754 | 26995340 | 34 | 18075 | |||
| 2026-05-07 | 10-Q | 10-Q | 0001628280-26-032293 | 001-40632 | 26954726 | 34 | 8713771 | 1 | 1 | |
| 2026-05-07 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-211948 | 001-40632 | 26953467 | 34 | 248723 | 1 | 1 |
| 2026-04-28 | ARS | ARS | 0001140361-26-017481 | 001-40632 | 26908553 | 34 | 1686857 | |||
| 2026-04-28 | DEFA14A | DEFA14A | 0001140361-26-017480 | 001-40632 | 26908540 | 34 | 3812723 | |||
| 2026-04-28 | DEF 14A | DEF 14A | 0001140361-26-017479 | 001-40632 | 26908515 | 34 | 7147394 | 1 | 1 | |
| 2026-04-09 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001104659-26-041573 | 005-92754 | 26852558 | 34 | 15510 | |||
| 2026-03-26 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000102909-26-001029 | 005-92754 | 26799704 | 34 | 7213 | |||
| 2026-03-13 | 4 | xslF345X05/form4-03132026_100343.xml | 0001874041-26-000004 | 4684 | ||||||
| 2026-03-12 | 4 | xslF345X05/form4-03122026_080314.xml | 0001337252-26-000001 | 7535 | ||||||
| 2026-03-12 | 4 | xslF345X05/form4-03122026_080318.xml | 0001873091-26-000003 | 25575 | ||||||
| 2026-03-12 | 4 | xslF345X05/form4-03122026_080302.xml | 0001991396-26-000001 | 25600 | ||||||
| 2026-03-12 | 4 | xslF345X05/form4-03122026_080314.xml | 0001872873-26-000003 | 25592 | ||||||
| 2026-03-12 | 4 | xslF345X05/form4-03122026_080323.xml | 0001878824-26-000001 | 20013 | ||||||
| 2026-03-12 | 4 | xslF345X05/form4-03122026_080319.xml | 0001874041-26-000003 | 25580 | ||||||
| 2026-03-12 | 4 | xslF345X05/form4-03122026_080344.xml | 0001515140-26-000001 | 7549 | ||||||
| 2026-02-27 | S-8 | S-8 | 0001193125-26-082841 | 333-293867 | 26700589 | 33 | 193648 | 1 | 1 | |
| 2026-02-26 | 10-K | 10-K | 0001628280-26-012352 | 001-40632 | 26689578 | 34 | 13182076 | 1 | 1 | |
| 2026-02-26 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-076768 | 001-40632 | 26688438 | 34 | 303931 | 1 | 1 |
| 2026-02-20 | 4 | xslF345X05/form4-02202026_100254.xml | 0001872873-26-000002 | 9063 | ||||||
| 2026-02-20 | 4 | xslF345X05/form4-02202026_100256.xml | 0001874041-26-000002 | 9061 | ||||||
| 2026-02-20 | 4 | xslF345X05/form4-02202026_100232.xml | 0001873091-26-000002 | 9051 | ||||||
| 2026-01-13 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-011748 | 001-40632 | 26530218 | 34 | 156718 | 1 | 1 |
| 2025-11-20 | 4 | xslF345X05/form4-11212025_121157.xml | 0001874041-25-000002 | 26001 | ||||||
| 2025-11-20 | 4 | xslF345X05/form4-11212025_121133.xml | 0001991396-25-000002 | 20585 | ||||||
| 2025-11-20 | 4 | xslF345X05/form4-11212025_121102.xml | 0001873091-25-000002 | 25989 | ||||||
| 2025-11-20 | 4 | xslF345X05/form4-11212025_121127.xml | 0001878824-25-000002 | 14995 | ||||||
| 2025-11-20 | 4 | xslF345X05/form4-11202025_111154.xml | 0001872873-25-000002 | 26015 | ||||||
| 2025-11-20 | 4 | xslF345X05/form4-11202025_111124.xml | 0001515140-25-000002 | 7550 | ||||||
| 2025-11-20 | 4 | xslF345X05/form4-11202025_111125.xml | 0001337252-25-000004 | 7536 | ||||||
| 2025-11-17 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001193125-25-284205 | 005-92754 | 251490061 | 34 | 193992 | |||
| 2025-11-12 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001398344-25-020758 | 005-92754 | 251471538 | 34 | 7546 | |||
| 2025-11-05 | 10-Q | 10-Q | 0001628280-25-049697 | 001-40632 | 251455161 | 34 | 10470620 | 1 | 1 | |
| 2025-11-05 | 8-K | 8-K | 2.02,9.01 | 0001193125-25-266973 | 001-40632 | 251454202 | 34 | 274095 | 1 | 1 |
| 2025-08-20 | 4 | xslF345X05/form4-08202025_090828.xml | 0001415889-25-022524 | 25999 | ||||||
| 2025-08-20 | 4 | xslF345X05/form4-08202025_090849.xml | 0001415889-25-022523 | 20585 | ||||||
| 2025-08-20 | 4 | xslF345X05/form4-08202025_090831.xml | 0001415889-25-022522 | 25980 | ||||||
| 2025-08-20 | 4 | xslF345X05/form4-08202025_090803.xml | 0001415889-25-022521 | 26013 | ||||||
| 2025-08-20 | 4 | xslF345X05/form4-08202025_090817.xml | 0001415889-25-022520 | 14993 | ||||||
| 2025-08-20 | 4 | xslF345X05/form4-08202025_090800.xml | 0001415889-25-022518 | 7545 | ||||||
| 2025-08-20 | 4 | xslF345X05/form4-08202025_090818.xml | 0001415889-25-022516 | 7535 | ||||||
| 2025-08-06 | 10-Q | 10-Q | 0001628280-25-038422 | 001-40632 | 251190688 | 34 | 10134562 | 1 | 1 | |
| 2025-08-06 | 8-K | 8-K | 2.02,9.01 | 0001193125-25-174459 | 001-40632 | 251189689 | 34 | 273161 | 1 | 1 |
| 2025-07-29 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000932471-25-000774 | 005-92754 | 251159047 | 34 | 6253 | |||
| 2025-07-18 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0002052113-25-003345 | 005-92754 | 251134032 | 34 | 11235 | |||
| 2025-06-24 | 8-K | 8-K | 5.07 | 0001193125-25-145725 | 001-40632 | 251068999 | 34 | 141085 | 1 | 1 |
| 2025-06-20 | 4 | xslF345X05/form4-06202025_080655.xml | 0001415889-25-017868 | 8347 | ||||||
| 2025-06-20 | 3 | xslF345X02/form3-06202025_080615.xml | 0001415889-25-017861 | 9826 | ||||||
| 2025-06-20 | 4 | xslF345X05/form4-06202025_080610.xml | 0001415889-25-017853 | 8078 | ||||||
| 2025-06-20 | 4 | xslF345X05/form4-06202025_080611.xml | 0001415889-25-017844 | 8070 | ||||||
| 2025-06-20 | 4 | xslF345X05/form4-06202025_080658.xml | 0001415889-25-017840 | 8078 | ||||||
| 2025-06-20 | 4 | xslF345X05/form4-06202025_080640.xml | 0001415889-25-017838 | 8078 | ||||||
| 2025-06-09 | 4 | xslF345X05/form4-06092025_090626.xml | 0001415889-25-016319 | 7064 | ||||||
| 2025-06-09 | 4 | xslF345X05/form4-06092025_090627.xml | 0001415889-25-016316 | 6929 | ||||||
| 2025-06-09 | 4 | xslF345X05/form4-06092025_090659.xml | 0001415889-25-016312 | 7055 | ||||||
| 2025-06-09 | 4 | xslF345X05/form4-06092025_080607.xml | 0001415889-25-016306 | 7064 | ||||||
| 2025-06-03 | 4 | xslF345X05/form4-06032025_090608.xml | 0001415889-25-015442 | 5193 | ||||||
| 2025-05-30 | SD | SD | 0001193125-25-132091 | 001-40632 | 251010665 | 34 | 22565 | |||
| 2025-05-21 | 4 | xslF345X05/form4-05212025_090504.xml | 0001415889-25-013984 | 14993 | ||||||
| 2025-05-21 | 4 | xslF345X05/form4-05212025_090536.xml | 0001415889-25-013982 | 26012 | ||||||
| 2025-05-21 | 4 | xslF345X05/form4-05212025_090505.xml | 0001415889-25-013980 | 25973 | ||||||
| 2025-05-21 | 4 | xslF345X05/form4-05212025_090534.xml | 0001415889-25-013978 | 20585 | ||||||
| 2025-05-21 | 4 | xslF345X05/form4-05212025_090505.xml | 0001415889-25-013976 | 26001 | ||||||
| 2025-05-21 | 4 | xslF345X05/form4-05212025_090559.xml | 0001415889-25-013974 | 7548 | ||||||
| 2025-05-15 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001398344-25-009599 | 005-92754 | 25951336 | 34 | 7476 | |||
| 2025-05-08 | 10-Q | 10-Q | 0001628280-25-023927 | 001-40632 | 25927466 | 34 | 9582343 | 1 | 1 | |
| 2025-05-08 | 8-K | 8-K | 2.02,9.01 | 0001193125-25-115965 | 001-40632 | 25926204 | 34 | 258500 | 1 | 1 |
| 2025-04-30 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000932471-25-000481 | 005-92754 | 25891954 | 34 | 6252 | |||
| 2025-04-28 | ARS | ARS | 0001140361-25-016037 | 001-40632 | 25880690 | 34 | 1798113 | |||
| 2025-04-28 | DEFA14A | DEFA14A | 0001140361-25-016036 | 001-40632 | 25880672 | 34 | 3697521 | |||
| 2025-04-28 | DEF 14A | DEF 14A | 0001140361-25-016032 | 001-40632 | 25880639 | 34 | 6919136 | 1 | 1 | |
| 2025-03-12 | 4 | xslF345X05/form4-03122025_090346.xml | 0001415889-25-007891 | 14901 | ||||||
| 2025-03-12 | 4 | xslF345X05/form4-03122025_090353.xml | 0001415889-25-007890 | 14943 | ||||||
| 2025-03-12 | 4 | xslF345X05/form4-03122025_090352.xml | 0001415889-25-007889 | 14922 | ||||||
| 2025-03-12 | 4 | xslF345X05/form4-03122025_090329.xml | 0001415889-25-007888 | 14917 | ||||||
| 2025-03-12 | 4 | xslF345X05/form4-03122025_090354.xml | 0001415889-25-007887 | 7555 | ||||||
| 2025-03-06 | 4 | xslF345X05/form4-03062025_100342.xml | 0001415889-25-007283 | 8408 | ||||||
| 2025-03-06 | 4 | xslF345X05/form4-03062025_100326.xml | 0001415889-25-007282 | 8419 | ||||||
| 2025-03-06 | 4 | xslF345X05/form4-03062025_100358.xml | 0001415889-25-007281 | 8412 | ||||||
| 2025-03-06 | 4 | xslF345X05/form4-03062025_100338.xml | 0001415889-25-007280 | 8384 | ||||||
| 2025-03-06 | 4 | xslF345X05/form4-03062025_100358.xml | 0001415889-25-007279 | 8403 | ||||||
| 2025-02-28 | S-8 | S-8 | 0001193125-25-042608 | 333-285446 | 25691325 | 33 | 247193 | 1 | 1 | |
| 2025-02-28 | 10-K | 10-K | 0001628280-25-008780 | 001-40632 | 25681070 | 34 | 12306568 | 1 | 1 | |
| 2025-02-27 | 8-K | 8-K | 2.02,9.01 | 0001193125-25-039225 | 001-40632 | 25678768 | 34 | 306943 | 1 | 1 |
| 2025-02-20 | 4 | xslF345X05/form4-02202025_110252.xml | 0001415889-25-004928 | 9059 | ||||||
| 2025-02-20 | 4 | xslF345X05/form4-02202025_110227.xml | 0001415889-25-004926 | 9071 | ||||||
| 2025-02-20 | 4 | xslF345X05/form4-02202025_110246.xml | 0001415889-25-004924 | 9074 | ||||||
| 2025-02-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001415889-25-004271 | 005-92754 | 25631683 | 34 | 16667 | |||
| 2025-02-05 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0002012383-25-001200 | 005-92754 | 25592217 | 34 | 11856 | |||
| 2025-01-15 | 8-K | 8-K | 2.02,9.01 | 0001193125-25-006599 | 001-40632 | 25531241 | 34 | 162852 | 1 | 1 |
| 2024-11-20 | 4 | xslF345X05/form4-11202024_111129.xml | 0001415889-24-027369 | 14946 | ||||||
| 2024-11-20 | 4 | xslF345X05/form4-11202024_111121.xml | 0001415889-24-027368 | 20337 | ||||||
| 2024-11-20 | 4 | xslF345X05/form4-11202024_111121.xml | 0001415889-24-027367 | 20367 | ||||||
| 2024-11-20 | 4 | xslF345X05/form4-11202024_111152.xml | 0001415889-24-027366 | 20349 | ||||||
| 2024-11-20 | 4 | xslF345X05/form4-11202024_111112.xml | 0001415889-24-027365 | 20359 | ||||||
| 2024-11-20 | 4 | xslF345X05/form4-11202024_111103.xml | 0001415889-24-027364 | 7556 | ||||||
| 2024-11-14 | SC 13G | CYTEK BIOSCIENCES, INC. | 0000902664-24-006628 | 005-92754 | 241463414 | 34 | 43603 | |||
| 2024-11-14 | SC 13G/A | fp0090934-11_sc13ga.htm | 0001398344-24-020821 | 005-92754 | 241460037 | 34 | 65144 | |||
| 2024-11-07 | 10-Q | 10-Q | 0001628280-24-045834 | 001-40632 | 241432401 | 34 | 10233738 | 1 | 1 | |
| 2024-11-05 | 8-K | 8-K | 2.02,9.01 | 0001193125-24-251268 | 001-40632 | 241427859 | 34 | 276515 | 1 | 1 |
| 2024-09-16 | 4 | xslF345X05/form4-09162024_100916.xml | 0001415889-24-023460 | 4692 | ||||||
| 2024-09-12 | 8-K | 8-K | 5.02 | 0001193125-24-217558 | 001-40632 | 241293814 | 34 | 138802 | 1 | 1 |
| 2024-08-21 | 4 | xslF345X05/form4-08212024_100824.xml | 0001415889-24-021864 | 7556 | ||||||
| 2024-08-21 | 4 | xslF345X05/form4-08212024_100843.xml | 0001415889-24-021860 | 20540 | ||||||
| 2024-08-21 | 4 | xslF345X05/form4-08212024_100843.xml | 0001415889-24-021858 | 20365 | ||||||
| 2024-08-21 | 4 | xslF345X05/form4-08212024_100846.xml | 0001415889-24-021857 | 20358 | ||||||
| 2024-08-21 | 4 | xslF345X05/form4-08212024_100816.xml | 0001415889-24-021856 | 20363 | ||||||
| 2024-08-21 | 4 | xslF345X05/form4-08212024_100840.xml | 0001415889-24-021855 | 20347 | ||||||
| 2024-08-21 | 4 | xslF345X05/form4-08212024_100852.xml | 0001415889-24-021854 | 14942 | ||||||
| 2024-08-06 | 10-Q | 10-Q | 0001628280-24-035264 | 001-40632 | 241180513 | 34 | 9815369 | 1 | 1 | |
| 2024-08-06 | 8-K | 8-K | 2.02,9.01 | 0001193125-24-194907 | 001-40632 | 241179515 | 34 | 276210 | 1 | 1 |
| 2024-06-11 | 8-K | 8-K | 5.07 | 0001193125-24-159094 | 001-40632 | 241035716 | 34 | 148668 | 1 | 1 |
| 2024-06-07 | 4 | xslF345X05/form4-06072024_110607.xml | 0001415889-24-016083 | 8358 | ||||||
| 2024-06-07 | 3 | xslF345X02/form3-06072024_110631.xml | 0001415889-24-016082 | 9598 | ||||||
| 2024-06-07 | 4 | xslF345X05/form4-06072024_110634.xml | 0001415889-24-016081 | 7712 | ||||||
| 2024-06-07 | 4 | xslF345X05/form4-06072024_100612.xml | 0001415889-24-016078 | 7721 | ||||||
| 2024-06-07 | 4 | xslF345X05/form4-06072024_100635.xml | 0001415889-24-016077 | 7721 | ||||||
| 2024-06-07 | 4 | xslF345X05/form4-06072024_100635.xml | 0001415889-24-016076 | 7586 | ||||||
| 2024-05-31 | SD | SD | 0001193125-24-151917 | 001-40632 | 241010517 | 34 | 22199 | |||
| 2024-05-22 | 4 | xslF345X05/form4-05222024_100502.xml | 0001415889-24-014149 | 20554 | ||||||
| 2024-05-22 | 4 | xslF345X05/form4-05222024_100556.xml | 0001415889-24-014148 | 20358 | ||||||
| 2024-05-22 | 4 | xslF345X05/form4-05222024_100534.xml | 0001415889-24-014147 | 20360 | ||||||
| 2024-05-22 | 4 | xslF345X05/form4-05222024_100540.xml | 0001415889-24-014146 | 20362 | ||||||
| 2024-05-22 | 4 | xslF345X05/form4-05222024_100555.xml | 0001415889-24-014145 | 20336 | ||||||
| 2024-05-22 | 4 | xslF345X05/form4-05222024_100536.xml | 0001415889-24-014144 | 14980 | ||||||
| 2024-05-15 | 4 | xslF345X05/form4-05152024_110545.xml | 0001415889-24-013281 | 8516 | ||||||
| 2024-05-08 | 10-Q | 10-Q | 0001628280-24-021723 | 001-40632 | 24926828 | 34 | 9783819 | 1 | 1 | |
| 2024-05-08 | 8-K | 8-K | 2.02,9.01 | 0001193125-24-134238 | 001-40632 | 24926504 | 34 | 254663 | 1 | 1 |
| 2024-04-25 | ARS | ARS | 0001140361-24-022073 | 001-40632 | 24876777 | 34 | 1963389 | |||
| 2024-04-25 | DEFA14A | DEFA14A | 0001140361-24-022067 | 001-40632 | 24876743 | 34 | 1223495 | |||
| 2024-04-25 | DEF 14A | DEF 14A | 0001140361-24-022063 | 001-40632 | 24876723 | 34 | 6106242 | 1 | 1 | |
| 2024-04-23 | 4 | xslF345X05/form4-04232024_100439.xml | 0001415889-24-011390 | 5407 | ||||||
| 2024-04-11 | 4 | xslF345X05/form4-04112024_100410.xml | 0001415889-24-010714 | 6419 | ||||||
| 2024-04-09 | 144 | xsl144X01/primary_doc.xml | 0001950047-24-003012 | 001-40632 | 24832987 | 33 | 6821 | |||
| 2024-03-21 | 4 | xslF345X05/form4-03212024_100334.xml | 0001415889-24-008881 | 8796 | ||||||
| 2024-03-20 | 3 | xslF345X02/form3-03212024_120319.xml | 0001415889-24-008799 | 9627 | ||||||
| 2024-03-19 | 4 | xslF345X05/form4-03192024_100347.xml | 0001415889-24-008641 | 7413 | ||||||
| 2024-03-19 | 8-K | 8-K | 5.02,9.01 | 0001193125-24-071467 | 001-40632 | 24764725 | 34 | 220001 | 1 | 1 |
| 2024-03-18 | 144 | xsl144X01/primary_doc.xml | 0001950047-24-002469 | 001-40632 | 24759583 | 33 | 6113 | |||
| 2024-03-14 | S-8 | S-8 | 0001193125-24-067926 | 333-277936 | 24750482 | 33 | 86763 | |||
| 2024-03-13 | 4 | xslF345X05/form4-03132024_100322.xml | 0001415889-24-007872 | 9287 | ||||||
| 2024-03-13 | 4 | xslF345X05/form4-03132024_100335.xml | 0001415889-24-007870 | 9317 | ||||||
| 2024-03-13 | 4 | xslF345X05/form4-03132024_100332.xml | 0001415889-24-007868 | 9293 | ||||||
| 2024-03-13 | 4 | xslF345X05/form4-03132024_100343.xml | 0001415889-24-007865 | 9292 | ||||||
| 2024-03-13 | 4 | xslF345X05/form4-03132024_100341.xml | 0001415889-24-007863 | 9387 | ||||||
| 2024-03-13 | 4 | xslF345X05/form4-03132024_100333.xml | 0001415889-24-007861 | 9275 | ||||||
| 2024-03-13 | 10-K | 10-K | 0001628280-24-010933 | 001-40632 | 24746569 | 34 | 14336973 | 1 | 1 | |
| 2024-03-08 | 4 | xslF345X05/form4-03082024_110327.xml | 0001415889-24-007440 | 8369 | ||||||
| 2024-03-08 | 4 | xslF345X05/form4-03082024_110311.xml | 0001415889-24-007439 | 8409 | ||||||
| 2024-03-08 | 4 | xslF345X05/form4-03082024_110327.xml | 0001415889-24-007438 | 8376 | ||||||
| 2024-03-08 | 4 | xslF345X05/form4-03082024_110341.xml | 0001415889-24-007437 | 8373 | ||||||
| 2024-03-08 | 4 | xslF345X05/form4-03082024_110313.xml | 0001415889-24-007436 | 8345 | ||||||
| 2024-03-08 | 4 | xslF345X05/form4-03082024_110324.xml | 0001415889-24-007435 | 8364 | ||||||
| 2024-03-01 | NT 10-K | NT 10-K | 0001193125-24-055924 | 001-40632 | 24709585 | 34 | 88420 | |||
| 2024-03-01 | 8-K | 8-K | 2.02,9.01 | 0001193125-24-054312 | 001-40632 | 24706725 | 34 | 378100 | 1 | 1 |
| 2024-02-27 | 8-K | 8-K | 5.02 | 0001193125-24-046891 | 001-40632 | 24681817 | 34 | 147696 | 1 | 1 |
| 2024-02-22 | SC 13G | SC 13G | 0001104659-24-026668 | 005-92754 | 24666753 | 34 | 73856 | |||
| 2024-02-22 | 4 | xslF345X05/form4-02222024_100239.xml | 0001415889-24-004899 | 9072 | ||||||
| 2024-02-22 | 4 | xslF345X05/form4-02222024_100248.xml | 0001415889-24-004898 | 9091 | ||||||
| 2024-02-22 | 4 | xslF345X05/form4-02222024_100212.xml | 0001415889-24-004895 | 9074 | ||||||
| 2024-02-22 | 4 | xslF345X05/form4-02222024_100233.xml | 0001415889-24-004892 | 9060 | ||||||
| 2024-02-22 | 4 | xslF345X05/form4-02222024_100242.xml | 0001415889-24-004886 | 9175 | ||||||
| 2024-02-22 | 4 | xslF345X05/form4-02222024_100207.xml | 0001415889-24-004881 | 9074 | ||||||
| 2024-02-14 | SC 13G/A | CYTEK BIOSCIENCES, INC. | 0000902664-24-001733 | 005-92754 | 24639452 | 34 | 63037 | |||
| 2024-02-14 | SC 13G/A | SC 13G/A | 0001193125-24-036185 | 005-92754 | 24638056 | 34 | 44567 | |||
| 2024-02-14 | SC 13G/A | SC 13G/A | 0001193125-24-036159 | 005-92754 | 24637933 | 34 | 46033 | |||
| 2024-02-14 | SC 13G | fp0086869-1_sc13g.htm | 0001398344-24-003121 | 005-92754 | 24636649 | 34 | 46131 | |||
| 2024-02-13 | SC 13G/A | SCHEDULE 13G/A | 0001104659-24-020725 | 005-92754 | 24627988 | 34 | 13142 | |||
| 2024-01-23 | SC 13G/A | us23285d1090_012324.txt | 0001086364-24-001700 | 005-92754 | 24552767 | 34 | 13691 | |||
| 2024-01-09 | 8-K | 8-K | 2.02,9.01 | 0001193125-24-004805 | 001-40632 | 24521654 | 34 | 159777 | 1 | 1 |
| 2023-12-27 | 4 | FORM 4 SUBMISSION | 0001209191-23-059819 | 5583 | ||||||
| 2023-12-21 | 4 | FORM 4 SUBMISSION | 0001209191-23-059472 | 5475 | ||||||
| 2023-12-19 | 144 | xsl144X01/primary_doc.xml | 0001950047-23-006319 | 001-40632 | 231497719 | 33 | 6243 | |||
| 2023-11-28 | 8-K | 8-K | 7.01,9.01 | 0001193125-23-283662 | 001-40632 | 231441878 | 34 | 2337360 | 1 | 1 |
| 2023-11-27 | 4 | FORM 4 SUBMISSION | 0001209191-23-056733 | 5478 | ||||||
| 2023-11-27 | 4 | FORM 4 SUBMISSION | 0001209191-23-056732 | 4657 | ||||||
| 2023-11-21 | 4 | FORM 4 SUBMISSION | 0001209191-23-056353 | 17235 | ||||||
| 2023-11-21 | 4 | FORM 4 SUBMISSION | 0001209191-23-056351 | 15025 | ||||||
| 2023-11-21 | 4 | FORM 4 SUBMISSION | 0001209191-23-056350 | 15000 | ||||||
| 2023-11-21 | 4 | FORM 4 SUBMISSION | 0001209191-23-056349 | 15106 | ||||||
| 2023-11-21 | 4 | FORM 4 SUBMISSION | 0001209191-23-056348 | 15009 | ||||||
| 2023-11-21 | 4 | FORM 4 SUBMISSION | 0001209191-23-056347 | 14965 | ||||||
| 2023-11-15 | 144 | xsl144X01/primary_doc.xml | 0001950047-23-005022 | 001-40632 | 231410818 | 33 | 6105 | |||
| 2023-11-14 | 10-Q | 10-Q | 0001628280-23-038974 | 001-40632 | 231407257 | 34 | 9648897 | 1 | 1 | |
| 2023-11-13 | NT 10-Q | NT 10-Q | 0001193125-23-275998 | 001-40632 | 231398495 | 34 | 116744 | |||
| 2023-11-09 | 8-K | 8-K | 2.02,9.01 | 0001193125-23-274005 | 001-40632 | 231389854 | 34 | 223522 | 1 | 1 |
| 2023-11-08 | 4 | FORM 4 SUBMISSION | 0001209191-23-054731 | 5375 | ||||||
| 2023-11-07 | 8-K | 8-K | 2.02,9.01 | 0001193125-23-272504 | 001-40632 | 231384735 | 34 | 289074 | 1 | 1 |
| 2023-10-25 | 4 | FORM 4 SUBMISSION | 0001209191-23-053595 | 5478 | ||||||
| 2023-10-24 | 144 | xsl144X01/primary_doc.xml | 0001950047-23-004596 | 001-40632 | 231342725 | 33 | 6286 | |||
| 2023-10-23 | 4 | FORM 4 SUBMISSION | 0001209191-23-053410 | 5370 | ||||||
| 2023-10-19 | 144 | xsl144X01/primary_doc.xml | 0001950047-23-004576 | 001-40632 | 231334769 | 33 | 6146 | |||
| 2023-10-11 | 4 | FORM 4 SUBMISSION | 0001209191-23-052657 | 5375 | ||||||
| 2023-10-05 | 4 | FORM 4 SUBMISSION | 0001209191-23-052263 | 4662 | ||||||
| 2023-09-26 | 4 | FORM 4 SUBMISSION | 0001209191-23-050611 | 5478 | ||||||
| 2023-09-20 | 4 | FORM 4 SUBMISSION | 0001209191-23-050201 | 5370 | ||||||
| 2023-09-19 | SC 13D/A | SC 13D/A | 0001104659-23-101999 | 005-92754 | 231264751 | 34 | 99688 | |||
| 2023-09-08 | 4 | FORM 4 SUBMISSION | 0001209191-23-048847 | 5375 | ||||||
| 2023-09-07 | 144 | xsl144X01/primary_doc.xml | 0001950047-23-003802 | 001-40632 | 231242431 | 33 | 6159 | |||
| 2023-08-29 | 3 | FORM 3 SUBMISSION | 0001209191-23-047658 | 10531 | ||||||
| 2023-08-28 | 4 | FORM 4 SUBMISSION | 0001209191-23-047533 | 5479 | ||||||
| 2023-08-21 | 4 | FORM 4 SUBMISSION | 0001209191-23-046833 | 15107 | ||||||
| 2023-08-21 | 4 | FORM 4 SUBMISSION | 0001209191-23-046832 | 15007 | ||||||
| 2023-08-21 | 4 | FORM 4 SUBMISSION | 0001209191-23-046829 | 9439 | ||||||
| 2023-08-21 | 4 | FORM 4 SUBMISSION | 0001209191-23-046828 | 15167 | ||||||
| 2023-08-21 | 4 | FORM 4 SUBMISSION | 0001209191-23-046827 | 15199 | ||||||
| 2023-08-21 | 4 | FORM 4 SUBMISSION | 0001209191-23-046826 | 15019 | ||||||
| 2023-08-21 | 4 | FORM 4 SUBMISSION | 0001209191-23-046824 | 17234 | ||||||
| 2023-08-21 | 144 | xsl144X01/primary_doc.xml | 0001950047-23-003299 | 001-40632 | 231189359 | 33 | 6139 | |||
| 2023-08-14 | 144 | xsl144X01/primary_doc.xml | 0001950047-23-003038 | 001-40632 | 231170518 | 33 | 6815 | |||
| 2023-08-08 | 4 | FORM 4 SUBMISSION | 0001209191-23-045099 | 5375 | ||||||
| 2023-08-08 | 10-Q | 10-Q | 0000950170-23-039899 | 001-40632 | 231151989 | 34 | 17042302 | 1 | 1 | |
| 2023-08-08 | 8-K | 8-K | 2.02,9.01 | 0001193125-23-206235 | 001-40632 | 231151596 | 34 | 282142 | 1 | 1 |
| 2023-07-25 | 4 | FORM 4 SUBMISSION | 0001209191-23-043340 | 5479 | ||||||
| 2023-07-24 | 144 | xsl144X01/primary_doc.xml | 0001950047-23-002487 | 001-40632 | 231105064 | 33 | 6286 | |||
| 2023-07-20 | 4 | FORM 4 SUBMISSION | 0001209191-23-042952 | 5370 | ||||||
| 2023-07-07 | 4 | FORM 4 SUBMISSION | 0001209191-23-041867 | 5375 | ||||||
| 2023-06-27 | 4 | FORM 4 SUBMISSION | 0001209191-23-039967 | 5517 | ||||||
| 2023-06-21 | 4 | FORM 4 SUBMISSION | 0001209191-23-038904 | 5370 | ||||||
| 2023-06-20 | 144 | xsl144X01/primary_doc.xml | 0001950047-23-001783 | 001-40632 | 231025551 | 33 | 6139 | |||
| 2023-06-20 | 8-K | 8-K | 5.07 | 0001193125-23-169513 | 001-40632 | 231023268 | 34 | 152170 | 1 | 1 |
| 2023-06-16 | 4 | FORM 4 SUBMISSION | 0001209191-23-038082 | 5247 | ||||||
| 2023-06-16 | 4 | FORM 4 SUBMISSION | 0001209191-23-038081 | 5242 | ||||||
| 2023-06-16 | 4 | FORM 4 SUBMISSION | 0001209191-23-038080 | 5109 | ||||||
| 2023-06-16 | 4 | FORM 4 SUBMISSION | 0001209191-23-038078 | 5239 | ||||||
| 2023-06-16 | 4 | FORM 4 SUBMISSION | 0001209191-23-038076 | 5233 | ||||||
| 2023-06-07 | 4 | FORM 4 SUBMISSION | 0001209191-23-035222 | 5375 | ||||||
| 2023-06-07 | 144 | xsl144X01/primary_doc.xml | 0001950047-23-001357 | 001-40632 | 23999027 | 33 | 6158 | |||
| 2023-05-25 | 4 | FORM 4 SUBMISSION | 0001209191-23-032259 | 5516 | ||||||
| 2023-05-19 | 4 | FORM 4 SUBMISSION | 0001209191-23-031276 | 17227 | ||||||
| 2023-05-19 | 4 | FORM 4 SUBMISSION | 0001209191-23-031266 | 14955 | ||||||
| 2023-05-19 | 4 | FORM 4 SUBMISSION | 0001209191-23-031265 | 9433 | ||||||
| 2023-05-19 | 4 | FORM 4 SUBMISSION | 0001209191-23-031264 | 15099 | ||||||
| 2023-05-19 | 4 | FORM 4 SUBMISSION | 0001209191-23-031262 | 14997 | ||||||
| 2023-05-19 | 4 | FORM 4 SUBMISSION | 0001209191-23-031260 | 15012 | ||||||
| 2023-05-19 | 4 | FORM 4 SUBMISSION | 0001209191-23-031246 | 14991 | ||||||
| 2023-05-15 | 144 | xsl144X01/primary_doc.xml | 0001950047-23-000614 | 001-40632 | 23923075 | 33 | 6104 | |||
| 2023-05-15 | 8-K/A | 8-K/A | 9.01 | 0001193125-23-144952 | 001-40632 | 23921876 | 34 | 496561 | 1 | 1 |
| 2023-05-10 | 4 | FORM 4 SUBMISSION | 0001209191-23-028568 | 5377 | ||||||
| 2023-05-09 | 10-Q | 10-Q | 0000950170-23-019777 | 001-40632 | 23902797 | 34 | 15114038 | 1 | 1 | |
| 2023-05-09 | 8-K | 8-K | 2.02,9.01 | 0001193125-23-139445 | 001-40632 | 23902471 | 34 | 280392 | 1 | 1 |
| 2023-05-08 | 144 | xsl144X01/primary_doc.xml | 0001950047-23-000450 | 001-40632 | 23898109 | 33 | 6228 | |||
| 2023-05-05 | SC 13G/A | us23285d1090_050423.txt | 0001306550-23-009134 | 005-92754 | 23892225 | 34 | 13548 | |||
| 2023-04-28 | ARS | FORM ARS | 0001140361-23-021537 | 001-40632 | 23866197 | 34 | 1644769 | |||
| 2023-04-28 | DEFA14A | DEFA14A | 0001140361-23-021531 | 001-40632 | 23866149 | 34 | 2261952 | |||
| 2023-04-28 | DEF 14A | DEF14A | 0001140361-23-021528 | 001-40632 | 23866077 | 34 | 2748065 | |||
| 2023-04-25 | 4 | FORM 4 SUBMISSION | 0001209191-23-025617 | 5519 | ||||||
| 2023-04-24 | 144 | xsl144X01/primary_doc.xml | 0001950047-23-000221 | 001-40632 | 23840356 | 33 | 6286 | |||
| 2023-04-20 | 4 | FORM 4 SUBMISSION | 0001209191-23-025029 | 5369 | ||||||
| 2023-04-19 | 144 | xsl144X01/primary_doc.xml | 0001950047-23-000176 | 001-40632 | 23830223 | 33 | 7557 | |||
| 2023-04-11 | 4 | FORM 4 SUBMISSION | 0001209191-23-024043 | 5374 | ||||||
| 2023-03-24 | 4 | FORM 4 SUBMISSION | 0001209191-23-021140 | 5516 | ||||||
| 2023-03-24 | 144 | xsl144X01/primary_doc.xml | 0001950047-23-000057 | 001-40632 | 23760259 | 33 | 7001 | |||
| 2023-03-21 | 4 | FORM 4 SUBMISSION | 0001209191-23-020402 | 5369 | ||||||
| 2023-03-20 | 144 | xsl144X01/primary_doc.xml | 0001950047-23-000050 | 001-40632 | 23746933 | 33 | 7547 | |||
| 2023-03-07 | 4 | FORM 4 SUBMISSION | 0001209191-23-016984 | 8395 | ||||||
| 2023-03-07 | 4 | FORM 4 SUBMISSION | 0001209191-23-016981 | 8442 | ||||||
| 2023-03-07 | 4 | FORM 4 SUBMISSION | 0001209191-23-016980 | 8403 | ||||||
| 2023-03-07 | 4 | FORM 4 SUBMISSION | 0001209191-23-016979 | 10691 | ||||||
| 2023-03-07 | 4 | FORM 4 SUBMISSION | 0001209191-23-016978 | 8503 | ||||||
| 2023-03-07 | 4 | FORM 4 SUBMISSION | 0001209191-23-016977 | 8422 | ||||||
| 2023-03-07 | 4 | FORM 4 SUBMISSION | 0001209191-23-016975 | 8363 | ||||||
| 2023-03-02 | S-8 | S-8 | 0001193125-23-056692 | 333-270200 | 23695650 | 33 | 78107 | |||
| 2023-03-01 | 10-K | 10-K | 0000950170-23-005610 | 001-40632 | 23694942 | 34 | 22020473 | 1 | 1 | |
| 2023-02-28 | 4 | FORM 4 SUBMISSION | 0001209191-23-013889 | 5487 | ||||||
| 2023-02-28 | 8-K | 8-K | 2.02,9.01 | 0001193125-23-053897 | 001-40632 | 23685646 | 34 | 326551 | 1 | 1 |
| 2023-02-28 | 8-K | 8-K | 2.01,9.01 | 0001193125-23-052702 | 001-40632 | 23678987 | 34 | 146238 | 1 | 1 |
| 2023-02-23 | 4 | FORM 4 SUBMISSION | 0001209191-23-012359 | 11390 | ||||||
| 2023-02-23 | 4 | FORM 4 SUBMISSION | 0001209191-23-012357 | 9364 | ||||||
| 2023-02-23 | 4 | FORM 4 SUBMISSION | 0001209191-23-012356 | 9157 | ||||||
| 2023-02-23 | 4 | FORM 4 SUBMISSION | 0001209191-23-012355 | 9325 | ||||||
| 2023-02-23 | 4 | FORM 4 SUBMISSION | 0001209191-23-012352 | 9263 | ||||||
| 2023-02-23 | 4 | FORM 4 SUBMISSION | 0001209191-23-012351 | 7558 | ||||||
| 2023-02-14 | SC 13G/A | CYTEK BIOSCIENCES, INC. | 0000902664-23-001808 | 005-92754 | 23629201 | 34 | 60164 | |||
| 2023-02-13 | 8-K | 8-K | 1.01,7.01,9.01 | 0001193125-23-035865 | 001-40632 | 23618783 | 34 | 217317 | 1 | 1 |
| 2023-02-10 | 4 | FORM 4 SUBMISSION | 0001209191-23-008517 | 5338 | ||||||
| 2023-02-09 | SC 13G | SCHEDULE 13G | 0001104659-23-015749 | 005-92754 | 23602901 | 34 | 13007 | |||
| 2023-02-08 | 4 | FORM 4 SUBMISSION | 0001209191-23-007911 | 5345 | ||||||
| 2023-02-07 | 4 | FORM 4 SUBMISSION | 0001209191-23-007670 | 6405 | ||||||
| 2023-02-03 | SC 13G | us23285d1090_020323.txt | 0001306550-23-007104 | 005-92754 | 23584714 | 34 | 13391 | |||
| 2023-01-25 | 4 | FORM 4 SUBMISSION | 0001209191-23-004922 | 5486 | ||||||
| 2023-01-20 | 4 | FORM 4 SUBMISSION | 0001209191-23-004327 | 5339 | ||||||
| 2023-01-10 | 4 | FORM 4 SUBMISSION | 0001209191-23-002859 | 5344 | ||||||
| 2022-12-29 | 4 | FORM 4 SUBMISSION | 0001209191-22-062882 | 5444 | ||||||
| 2022-12-20 | 4 | FORM 4 SUBMISSION | 0001209191-22-062236 | 5340 | ||||||
| 2022-12-09 | 4 | FORM 4 SUBMISSION | 0001209191-22-060573 | 6872 | ||||||
| 2022-11-30 | 4 | FORM 4 SUBMISSION | 0001209191-22-059113 | 10653 | ||||||
| 2022-11-28 | 4 | FORM 4 SUBMISSION | 0001209191-22-058890 | 5447 | ||||||
| 2022-11-22 | 4 | FORM 4 SUBMISSION | 0001209191-22-058475 | 9158 | ||||||
| 2022-11-22 | 4 | FORM 4 SUBMISSION | 0001209191-22-058474 | 11390 | ||||||
| 2022-11-22 | 4 | FORM 4 SUBMISSION | 0001209191-22-058472 | 9122 | ||||||
| 2022-11-22 | 4 | FORM 4 SUBMISSION | 0001209191-22-058467 | 9262 | ||||||
| 2022-11-22 | 4 | FORM 4 SUBMISSION | 0001209191-22-058465 | 9159 | ||||||
| 2022-11-16 | 4 | FORM 4 SUBMISSION | 0001209191-22-057368 | 9019 | ||||||
| 2022-11-09 | 10-Q | 10-Q | 0000950170-22-023935 | 001-40632 | 221373248 | 34 | 17169699 | 1 | 1 | |
| 2022-11-09 | 8-K | 8-K | 2.02,9.01 | 0001193125-22-281247 | 001-40632 | 221373029 | 34 | 301027 | 1 | 1 |
| 2022-11-08 | 4 | FORM 4 SUBMISSION | 0001209191-22-056149 | 5345 | ||||||
| 2022-11-02 | 4 | FORM 4 SUBMISSION | 0001209191-22-055368 | 8247 | ||||||
| 2022-11-02 | 3 | FORM 3 SUBMISSION | 0001209191-22-055367 | 6505 | ||||||
| 2022-11-01 | 8-K | 8-K | 5.02,9.01 | 0001193125-22-275058 | 001-40632 | 221351467 | 34 | 208715 | 1 | 1 |
| 2022-10-25 | 4 | FORM 4 SUBMISSION | 0001209191-22-054563 | 5447 | ||||||
| 2022-10-20 | 4 | FORM 4 SUBMISSION | 0001209191-22-054210 | 5340 | ||||||
| 2022-10-11 | 4 | FORM 4 SUBMISSION | 0001209191-22-053368 | 5345 | ||||||
| 2022-09-28 | 4 | FORM 4 SUBMISSION | 0001209191-22-051488 | 5447 | ||||||
| 2022-09-20 | 4 | FORM 4 SUBMISSION | 0001209191-22-050770 | 5340 | ||||||
| 2022-09-09 | 4 | FORM 4 SUBMISSION | 0001209191-22-049368 | 5345 | ||||||
| 2022-08-26 | S-3ASR | S-3ASR | 0001193125-22-231398 | 333-267118 | 221206101 | 33 | 1331678 | |||
| 2022-08-25 | 4 | FORM 4 SUBMISSION | 0001209191-22-047576 | 4951 | ||||||
| 2022-08-19 | 4 | FORM 4 SUBMISSION | 0001209191-22-046949 | 11388 | ||||||
| 2022-08-19 | 4 | FORM 4 SUBMISSION | 0001209191-22-046948 | 9162 | ||||||
| 2022-08-19 | 4 | FORM 4 SUBMISSION | 0001209191-22-046947 | 9156 | ||||||
| 2022-08-19 | 4 | FORM 4 SUBMISSION | 0001209191-22-046946 | 9260 | ||||||
| 2022-08-19 | 4 | FORM 4 SUBMISSION | 0001209191-22-046945 | 9324 | ||||||
| 2022-08-10 | 4 | FORM 4 SUBMISSION | 0001209191-22-045286 | 5345 | ||||||
| 2022-08-10 | 10-Q | 10-Q | 0000950170-22-016500 | 001-40632 | 221152278 | 34 | 15214737 | 1 | 1 | |
| 2022-08-10 | 8-K | 8-K | 2.02,9.01 | 0001193125-22-217376 | 001-40632 | 221152073 | 34 | 301168 | 1 | 1 |
| 2022-08-03 | 4 | FORM 4 SUBMISSION | 0001209191-22-044309 | 5651 | ||||||
| 2022-08-03 | SC 13G/A | formsc13ga.htm | 0001493152-22-021197 | 005-92754 | 221133761 | 34 | 199064 | |||
| 2022-07-20 | 4 | FORM 4 SUBMISSION | 0001209191-22-042761 | 5340 | ||||||
| 2022-07-08 | 4 | FORM 4 SUBMISSION | 0001209191-22-041705 | 5345 | ||||||
| 2022-06-22 | 4 | FORM 4 SUBMISSION | 0001209191-22-038768 | 5339 | ||||||
| 2022-06-09 | 4 | FORM 4 SUBMISSION | 0001209191-22-035656 | 5345 | ||||||
| 2022-06-06 | 8-K | 8-K | 5.07 | 0001193125-22-168332 | 001-40632 | 22998192 | 34 | 150681 | 1 | 1 |
| 2022-06-03 | 4 | FORM 4 SUBMISSION | 0001209191-22-034261 | 5200 | ||||||
| 2022-06-03 | 4 | FORM 4 SUBMISSION | 0001209191-22-034259 | 5206 | ||||||
| 2022-06-03 | 4 | FORM 4 SUBMISSION | 0001209191-22-034257 | 5209 | ||||||
| 2022-06-03 | 4 | FORM 4 SUBMISSION | 0001209191-22-034253 | 5289 | ||||||
| 2022-06-03 | 3 | FORM 3 SUBMISSION | 0001209191-22-034245 | 6229 | ||||||
| 2022-06-03 | 4 | FORM 4 SUBMISSION | 0001209191-22-034227 | 5427 | ||||||
| 2022-06-03 | 3 | FORM 3 SUBMISSION | 0001209191-22-034218 | 6319 | ||||||
| 2022-05-20 | 4 | FORM 4 SUBMISSION | 0001209191-22-031172 | 11382 | ||||||
| 2022-05-20 | 4 | FORM 4 SUBMISSION | 0001209191-22-031170 | 9160 | ||||||
| 2022-05-20 | 4 | FORM 4 SUBMISSION | 0001209191-22-031168 | 9151 | ||||||
| 2022-05-20 | 4 | FORM 4 SUBMISSION | 0001209191-22-031164 | 9255 | ||||||
| 2022-05-20 | 4 | FORM 4 SUBMISSION | 0001209191-22-031161 | 9116 | ||||||
| 2022-05-12 | 4 | FORM 4 SUBMISSION | 0001209191-22-028461 | 5341 | ||||||
| 2022-05-12 | 10-Q | 10-Q | 0000950170-22-009425 | 001-40632 | 22915301 | 34 | 13034459 | 1 | 1 | |
| 2022-05-11 | 8-K | 8-K | 2.02,9.01 | 0001193125-22-147538 | 001-40632 | 22914010 | 34 | 277071 | 1 | 1 |
| 2022-04-27 | 4 | FORM 4 SUBMISSION | 0001209191-22-025897 | 8211 | ||||||
| 2022-04-27 | 3 | FORM 3 SUBMISSION | 0001209191-22-025896 | 6386 | ||||||
| 2022-04-21 | 4 | FORM 4 SUBMISSION | 0001209191-22-025251 | 5338 | ||||||
| 2022-04-14 | DEFA14A | DEFA14A | 0001140361-22-014567 | 001-40632 | 22827217 | 34 | 847286 | |||
| 2022-04-14 | DEF 14A | FORM DEF 14A | 0001140361-22-014564 | 001-40632 | 22827193 | 34 | 2056840 | |||
| 2022-04-08 | 4 | FORM 4 SUBMISSION | 0001209191-22-023887 | 5344 | ||||||
| 2022-03-23 | 4 | FORM 4 SUBMISSION | 0001209191-22-020814 | 5339 | ||||||
| 2022-03-17 | S-8 | S-8 | 0001193125-22-078438 | 333-263661 | 22749812 | 33 | 89801 | |||
| 2022-03-17 | 10-K | 10-K | 0000950170-22-004106 | 001-40632 | 22749101 | 34 | 14426628 | 1 | 1 | |
| 2022-03-16 | 4 | OWNERSHIP DOCUMENT | 0001104659-22-034568 | 15567 | ||||||
| 2022-03-14 | SC 13D/A | CYTEK BIOSCIENCES, INC. | 0001104659-22-033394 | 005-92754 | 22737426 | 34 | 83279 | |||
| 2022-03-11 | 4 | OWNERSHIP DOCUMENT | 0001104659-22-032990 | 17699 | ||||||
| 2022-03-08 | 4 | FORM 4 SUBMISSION | 0001209191-22-017217 | 10797 | ||||||
| 2022-03-08 | 4 | FORM 4 SUBMISSION | 0001209191-22-017212 | 11148 | ||||||
| 2022-03-08 | 4 | FORM 4 SUBMISSION | 0001209191-22-017206 | 7075 |
One latest value per concept from companyfacts (346 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 130.78M | 2026-10-31 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 | |
| dei | EntityPublicFloat | Entity Public Float | USD | 393.00M | 2025-06-30 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012352 | |
| ecd | CoSelectedMeasureAmt | CoSelectedMeasureAmt | USD | 201.49M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-28 | 0001140361-26-017479 | ||
| ecd | NonPeoNeoAvgCompActuallyPaidAmt | NonPeoNeoAvgCompActuallyPaidAmt | USD | 1.40M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-28 | 0001140361-26-017479 | ||
| ecd | NonPeoNeoAvgTotalCompAmt | NonPeoNeoAvgTotalCompAmt | USD | 1.78M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-28 | 0001140361-26-017479 | ||
| ecd | PeerGroupTotalShareholderRtnAmt | PeerGroupTotalShareholderRtnAmt | USD | 113.99 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-28 | 0001140361-26-017479 | ||
| ecd | PeoActuallyPaidCompAmt | PeoActuallyPaidCompAmt | USD | 3.64M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-28 | 0001140361-26-017479 | ||
| ecd | PeoTotalCompAmt | PeoTotalCompAmt | USD | 5.12M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-28 | 0001140361-26-017479 | ||
| ecd | TotalShareholderRtnAmt | TotalShareholderRtnAmt | USD | 26.92 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-28 | 0001140361-26-017479 | ||
| srt | StockRepurchaseProgramAuthorizedAmount1 | StockRepurchaseProgramAuthorizedAmount1 | USD | 50.00M | 2024-12-11 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012352 | |
| us-gaap | AccountsPayableAndAccruedLiabilitiesCurrent | Accounts Payable and Accrued Liabilities, Current | USD | 27.15M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 | |
| us-gaap | AccountsPayableTradeCurrent | Accounts Payable, Trade, Current | USD | 4.89M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 | |
| us-gaap | AccountsReceivableNetCurrent | Accounts Receivable, after Allowance for Credit Loss, Current | USD | 59.19M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 | |
| us-gaap | AccruedEmployeeBenefitsCurrent | Accrued Employee Benefits, Current | USD | 13.25M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 | |
| us-gaap | AccruedIncomeTaxesCurrent | Accrued Income Taxes, Current | USD | 2.56M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 | |
| us-gaap | AccruedLiabilitiesCurrent | Accrued Liabilities, Current | USD | 27.15M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 | |
| us-gaap | AccruedProfessionalFeesCurrent | Accrued Professional Fees, Current | USD | 8.82M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 | |
| us-gaap | AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment | Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | USD | 15.37M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 | |
| us-gaap | AccumulatedOtherComprehensiveIncomeLossNetOfTax | Accumulated Other Comprehensive Income (Loss), Net of Tax | USD | 2.64M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 | |
| us-gaap | AdditionalPaidInCapital | Additional Paid in Capital | USD | 457.44M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 | |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue | APIC, Share-based Payment Arrangement, Increase for Cost Recognition | USD | 4.85M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 |
| us-gaap | AllocatedShareBasedCompensationExpense | Share-based Payment Arrangement, Expense | USD | 15.05M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 |
| us-gaap | AllowanceForDoubtfulAccountsReceivable | Accounts Receivable, Allowance for Credit Loss | USD | 1.18M | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-07 | 0001628280-26-032293 | |
| us-gaap | AllowanceForDoubtfulAccountsReceivableRecoveries | Accounts Receivable, Allowance for Credit Loss, Recovery | USD | 0 | 2022-01-01 | 2022-12-31 | 2024 | FY | 10-K | 2025-02-28 | 0001628280-25-008780 |
| us-gaap | AllowanceForDoubtfulAccountsReceivableWriteOffs | Accounts Receivable, Allowance for Credit Loss, Writeoff | USD | 0 | 2026-01-01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-07 | 0001628280-26-032293 |
| us-gaap | AmortizationOfIntangibleAssets | Amortization of Intangible Assets | USD | 2.60M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 |
| us-gaap | AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares | 1.80M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 |
| us-gaap | AssetImpairmentCharges | Asset Impairment Charges | USD | 1.60M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 |
| us-gaap | Assets | Assets | USD | 446.14M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 | |
| us-gaap | AssetsCurrent | Assets, Current | USD | 378.94M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 | |
| us-gaap | AssetsFairValueDisclosure | Assets, Fair Value Disclosure | USD | 233.97M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 | |
| us-gaap | AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 | |
| us-gaap | AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax | USD | 365,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 | |
| us-gaap | AvailableForSaleDebtSecuritiesAmortizedCostBasis | Debt Securities, Available-for-sale, Amortized Cost | USD | 189.46M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecurities | Debt Securities, Available-for-sale | USD | 189.09M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 | |
| us-gaap | BusinessAcquisitionCostOfAcquiredEntityTransactionCosts | Business Acquisition, Transaction Costs | USD | 1.50M | 2023-03-31 | 2023 | Q1 | 10-Q | 2023-05-09 | 0000950170-23-019777 | |
| us-gaap | BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax | Business Acquisition, Pro Forma Income (Loss) from Continuing Operations, Net of Tax | USD | -13.95M | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-13 | 0001628280-24-010933 |
| us-gaap | BusinessAcquisitionsProFormaNetIncomeLoss | Business Acquisition, Pro Forma Net Income (Loss) | USD | -10.81M | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-13 | 0001628280-24-010933 |
| us-gaap | BusinessAcquisitionsProFormaRevenue | Business Acquisition, Pro Forma Revenue | USD | 197.96M | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-13 | 0001628280-24-010933 |
| us-gaap | BusinessCombinationAcquisitionRelatedCosts | Business Combination, Acquisition Related Costs | USD | 1.50M | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-13 | 0001628280-24-010933 |
| us-gaap | CapitalExpendituresIncurredButNotYetPaid | Capital Expenditures Incurred but Not yet Paid | USD | 44,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 |
| us-gaap | Cash | Cash | USD | 21.93M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 | |
| us-gaap | CashAndCashEquivalentsAtCarryingValue | Cash and Cash Equivalents, at Carrying Value | USD | 66.81M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | USD | 67.19M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | USD | -23.66M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 |
| us-gaap | CashFDICInsuredAmount | Cash, FDIC Insured Amount | USD | 250,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 | |
| us-gaap | ChangeInReportingEntityIncomeLossAfterTaxAttributableToParent | ChangeInReportingEntityIncomeLossAfterTaxAttributableToParent | USD | 26,000 | 2021-01-01 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-01 | 0000950170-23-005610 |
| us-gaap | CommercialPaperAtCarryingValue | Commercial Paper, at Carrying Value | USD | 1.99M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 | |
| us-gaap | CommonStockCapitalSharesReservedForFutureIssuance | Common Stock, Capital Shares Reserved for Future Issuance | shares | 5.77M | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-09-03 | 0000950170-21-001668 | |
| us-gaap | CommonStockParOrStatedValuePerShare | Common Stock, Par or Stated Value Per Share | USD/shares | 0.001 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 | |
| us-gaap | CommonStockSharesAuthorized | Common Stock, Shares Authorized | shares | 1.00B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 | |
| us-gaap | CommonStockSharesIssued | Common Stock, Shares, Issued | shares | 130.77M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 | |
| us-gaap | CommonStockSharesOutstanding | Common Stock, Shares, Outstanding | shares | 130.77M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 | |
| us-gaap | CommonStockValue | Common Stock, Value, Issued | USD | 131,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 | |
| us-gaap | ComprehensiveIncomeNetOfTax | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | USD | -36.72M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 |
| us-gaap | ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest | Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest | USD | 236,000 | 2023-01-01 | 2023-12-31 | 2024 | FY | 10-K | 2025-02-28 | 0001628280-25-008780 |
| us-gaap | ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest | Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest | USD | -236,000 | 2023-01-01 | 2023-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012352 |
| us-gaap | ContractWithCustomerLiability | Contract with Customer, Liability | USD | 50.82M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 | |
| us-gaap | ContractWithCustomerLiabilityCurrent | Contract with Customer, Liability, Current | USD | 30.28M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 | |
| us-gaap | ContractWithCustomerLiabilityNoncurrent | Contract with Customer, Liability, Noncurrent | USD | 18.74M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 | |
| us-gaap | ContractWithCustomerLiabilityRevenueRecognized | Contract with Customer, Liability, Revenue Recognized | USD | 47.22M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 |
| us-gaap | CostOfGoodsAndServicesSold | Cost of Goods and Services Sold | USD | 64.70M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 |
| us-gaap | CurrentFederalTaxExpenseBenefit | Current Federal Tax Expense (Benefit) | USD | -553,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012352 |
| us-gaap | CurrentForeignTaxExpenseBenefit | Current Foreign Tax Expense (Benefit) | USD | 3.56M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012352 |
| us-gaap | CurrentIncomeTaxExpenseBenefit | Current Income Tax Expense (Benefit) | USD | 3.14M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012352 |
| us-gaap | CurrentStateAndLocalTaxExpenseBenefit | Current State and Local Tax Expense (Benefit) | USD | 129,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012352 |
| us-gaap | DebtInstrumentCarryingAmount | Long-term Debt, Gross | USD | 99,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 | |
| us-gaap | DeferredFederalIncomeTaxExpenseBenefit | Deferred Federal Income Tax Expense (Benefit) | USD | 28.14M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012352 |
| us-gaap | DeferredForeignIncomeTaxExpenseBenefit | Deferred Foreign Income Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012352 |
| us-gaap | DeferredIncomeTaxExpenseBenefit | Deferred Income Tax Expense (Benefit) | USD | -183,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 |
| us-gaap | DeferredIncomeTaxLiabilities | Deferred Tax Liabilities, Gross | USD | 3.44M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012352 | |
| us-gaap | DeferredOfferingCosts | Deferred Offering Costs | USD | 0 | 2022-06-30 | 2022 | Q2 | 10-Q | 2022-08-10 | 0000950170-22-016500 | |
| us-gaap | DeferredRevenue | Deferred Revenue | USD | 29.64M | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-08 | 0000950170-23-039899 | |
| us-gaap | DeferredRevenueCurrent | Deferred Revenue, Current | USD | 30.28M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 | |
| us-gaap | DeferredRevenueNoncurrent | Deferred Revenue, Noncurrent | USD | 18.74M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 | |
| us-gaap | DeferredRevenueRevenueRecognized1 | Deferred Revenue, Revenue Recognized | USD | 19.10M | 2023-01-01 | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-08 | 0000950170-23-039899 |
| us-gaap | DeferredStateAndLocalIncomeTaxExpenseBenefit | Deferred State and Local Income Tax Expense (Benefit) | USD | 5.42M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012352 |
| us-gaap | DeferredTaxAssetsDeferredIncome | Deferred Tax Assets, Deferred Income | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012352 | |
| us-gaap | DeferredTaxAssetsGross | Deferred Tax Assets, Gross | USD | 41.82M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012352 | |
| us-gaap | DeferredTaxAssetsInProcessResearchAndDevelopment | Deferred Tax Assets, in Process Research and Development | USD | 9.28M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012352 | |
| us-gaap | DeferredTaxAssetsInventory | Deferred Tax Assets, Inventory | USD | 1.39M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012352 | |
| us-gaap | DeferredTaxAssetsLiabilitiesNet | Deferred Tax Assets, Net | USD | 33.37M | 2024-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012352 | |
| us-gaap | DeferredTaxAssetsNet | Deferred Tax Assets, Net of Valuation Allowance | USD | 3.25M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012352 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwards | Deferred Tax Assets, Operating Loss Carryforwards | USD | 6.38M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012352 | |
| us-gaap | DeferredTaxAssetsTaxCreditCarryforwardsForeign | Deferred Tax Assets, Tax Credit Carryforwards, Foreign | USD | 1.47M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012352 | |
| us-gaap | DeferredTaxAssetsTaxCreditCarryforwardsResearch | Deferred Tax Assets, Tax Credit Carryforwards, Research | USD | 3.11M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012352 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost | USD | 4.91M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012352 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities | Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities | USD | 1.56M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012352 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLegalSettlements | Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Legal Settlements | USD | 1.84M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012352 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther | Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Other | USD | 1.62M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012352 | |
| us-gaap | DeferredTaxAssetsValuationAllowance | Deferred Tax Assets, Valuation Allowance | USD | 38.56M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012352 | |
| us-gaap | DeferredTaxLiabilities | Deferred Tax Liabilities, Net | USD | 182,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012352 | |
| us-gaap | DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts | Deferred Tax Liabilities, Deferred Expense, Capitalized Research and Development Costs | USD | 4.95M | 2022-12-31 | 2022 | FY | 10-K | 2023-03-01 | 0000950170-23-005610 | |
| us-gaap | DefinedContributionPlanEmployerDiscretionaryContributionAmount | Defined Contribution Plan, Employer Discretionary Contribution Amount | USD | 1.70M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 |
| us-gaap | Depreciation | Depreciation | USD | 3.40M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 |
| us-gaap | DepreciationDepletionAndAmortization | Depreciation, Depletion and Amortization | USD | 5.99M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 |
| us-gaap | EarningsPerShareBasic | Earnings Per Share, Basic | USD/shares | -0.09 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-13 | 0001628280-24-010933 |
| us-gaap | EarningsPerShareDiluted | Earnings Per Share, Diluted | USD/shares | -0.09 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-13 | 0001628280-24-010933 |
| us-gaap | EffectiveIncomeTaxRateContinuingOperations | Effective Income Tax Rate Reconciliation, Percent | pure | -0.033 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 |
| us-gaap | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | pure | 0.21 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012352 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent | pure | -0.981 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012352 |
| us-gaap | EffectiveIncomeTaxRateReconciliationDeductions | Effective Income Tax Rate Reconciliation, Deduction, Percent | pure | 0.392 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-01 | 0000950170-23-005610 |
| us-gaap | EffectiveIncomeTaxRateReconciliationFdiiPercent | EffectiveIncomeTaxRateReconciliationFdiiPercent | pure | 0.052 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012352 |
| us-gaap | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent | pure | 0.1 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012352 |
| us-gaap | EffectiveIncomeTaxRateReconciliationGiltiAmount | EffectiveIncomeTaxRateReconciliationGiltiAmount | USD | 4.39M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012352 |
| us-gaap | EffectiveIncomeTaxRateReconciliationGiltiPercent | EffectiveIncomeTaxRateReconciliationGiltiPercent | pure | -0.147 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012352 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Percent | pure | -0.129 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-13 | 0001628280-24-010933 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent | pure | -0.106 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012352 |
| us-gaap | EffectiveIncomeTaxRateReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent | pure | 0 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012352 |
| us-gaap | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent | pure | 0.003 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012352 |
| us-gaap | EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes | Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Percent | pure | 0 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012352 |
| us-gaap | EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings | Effective Income Tax Rate Reconciliation, Repatriation of Foreign Earnings, Percent | pure | -0.02 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012352 |
| us-gaap | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent | pure | -0.444 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012352 |
| us-gaap | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent | pure | -0.215 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012352 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxContingencies | Effective Income Tax Rate Reconciliation, Tax Contingency, Percent | pure | 0.019 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012352 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCredits | Effective Income Tax Rate Reconciliation, Tax Credit, Percent | pure | -0.015 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012352 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCreditsForeign | Effective Income Tax Rate Reconciliation, Tax Credit, Foreign, Percent | pure | -0.042 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012352 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCreditsOther | Effective Income Tax Rate Reconciliation, Tax Credit, Other, Percent | pure | 0.015 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-01 | 0000950170-23-005610 |
| us-gaap | EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | USD | 1.41M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 |
| us-gaap | EmployeeBenefitsAndShareBasedCompensation | Employee Benefits and Share-based Compensation | USD | 3.90M | 2022-01-01 | 2022-06-30 | 2022 | Q2 | 10-Q | 2022-08-10 | 0000950170-22-016500 |
| us-gaap | EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount | USD | 12.30M | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-05 | 0001628280-25-049697 | |
| us-gaap | EquityMethodInvestments | Equity Method Investments | USD | 0 | 2026-06-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 | |
| us-gaap | EquitySecuritiesFvNiGainLoss | Equity Securities, FV-NI, Gain (Loss) | USD | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-13 | 0001628280-24-010933 |
| us-gaap | FinancialInstrumentsOwnedDerivativesAndOtherContractualAgreementsAtFairValue | Financial Instruments, Owned, Derivatives and Other Contractual Agreements, at Fair Value | USD | 115.50M | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-07 | 0001628280-24-045834 | |
| us-gaap | FinancingReceivableAllowanceForCreditLosses | Financing Receivable, Allowance for Credit Loss | USD | 1.56M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 | |
| us-gaap | FinancingReceivableAllowanceForCreditLossesWriteOffs | Financing Receivable, Allowance for Credit Loss, Writeoff | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 |
| us-gaap | FiniteLivedIntangibleAssetsAccumulatedAmortization | Finite-Lived Intangible Assets, Accumulated Amortization | USD | 14.57M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 | |
| us-gaap | FiniteLivedIntangibleAssetsGross | Finite-Lived Intangible Assets, Gross | USD | 28.60M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 | |
| us-gaap | FiniteLivedIntangibleAssetsNet | Finite-Lived Intangible Assets, Net | USD | 14.03M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 | |
| us-gaap | FutureMinimumSubleaseRentalsSaleLeasebackTransactions | Future Minimum Sublease Rentals, Sale Leaseback Transactions | USD | 600,000 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-01 | 0000950170-23-005610 | |
| us-gaap | GainLossOnSaleOfPropertyPlantEquipment | Gain (Loss) on Disposition of Property Plant Equipment | USD | -234,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 |
| us-gaap | GainLossRelatedToLitigationSettlement | Gain (Loss) Related to Litigation Settlement | USD | -1.00M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012352 |
| us-gaap | GeneralAndAdministrativeExpense | General and Administrative Expense | USD | 53.66M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 |
| us-gaap | Goodwill | Goodwill | USD | 16.69M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 | |
| us-gaap | GrossProfit | Gross Profit | USD | 80.80M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 |
| us-gaap | IncomeLossAttributableToParent | Income (Loss) Attributable to Parent, before Tax | USD | -35.92M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic | Income (Loss) from Continuing Operations before Income Taxes, Domestic | USD | -44.49M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012352 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | USD | -29.84M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012352 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign | Income (Loss) from Continuing Operations before Income Taxes, Foreign | USD | 14.65M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012352 |
| us-gaap | IncomeLossFromContinuingOperationsPerBasicShare | Income (Loss) from Continuing Operations, Per Basic Share | USD/shares | -0.29 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 |
| us-gaap | IncomeLossFromContinuingOperationsPerDilutedShare | Income (Loss) from Continuing Operations, Per Diluted Share | USD/shares | -0.29 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 |
| us-gaap | IncomeTaxesPaidNet | Income Taxes Paid, Net | USD | -3.03M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 |
| us-gaap | IncomeTaxExpenseBenefit | Income Tax Expense (Benefit) | USD | 1.20M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 |
| us-gaap | IncomeTaxPaidFederalAfterRefundReceived | IncomeTaxPaidFederalAfterRefundReceived | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012352 |
| us-gaap | IncomeTaxPaidStateAndLocalAfterRefundReceived | IncomeTaxPaidStateAndLocalAfterRefundReceived | USD | 24,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012352 |
| us-gaap | IncomeTaxReceivable | Income Taxes Receivable | USD | 1.37M | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-12 | 0000950170-21-004256 | |
| us-gaap | IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount | USD | 29.29M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012352 |
| us-gaap | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount | USD | -6.27M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012352 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount | USD | 3.16M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012352 |
| us-gaap | IncomeTaxReconciliationOtherReconcilingItems | Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount | USD | -78,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012352 |
| us-gaap | IncomeTaxReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount | USD | 6.41M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012352 |
| us-gaap | IncomeTaxReconciliationTaxContingencies | Effective Income Tax Rate Reconciliation, Tax Contingency, Amount | USD | -562,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012352 |
| us-gaap | IncomeTaxReconciliationTaxCredits | Effective Income Tax Rate Reconciliation, Tax Credit, Amount | USD | 448,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012352 |
| us-gaap | IncreaseDecreaseInAccountsPayable | Increase (Decrease) in Accounts Payable | USD | -1.44M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 |
| us-gaap | IncreaseDecreaseInAccountsReceivable | Increase (Decrease) in Accounts Receivable | USD | -1.54M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 |
| us-gaap | IncreaseDecreaseInAccruedLiabilities | Increase (Decrease) in Accrued Liabilities | USD | 4.50M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 |
| us-gaap | IncreaseDecreaseInContractWithCustomerLiability | Increase (Decrease) in Contract with Customer, Liability | USD | 50.12M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 |
| us-gaap | IncreaseDecreaseInDeferredRevenue | Increase (Decrease) in Deferred Revenue | USD | 2.52M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 |
| us-gaap | IncreaseDecreaseInInventories | Increase (Decrease) in Inventories | USD | 4.71M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 |
| us-gaap | IncreaseDecreaseInOperatingLeaseLiability | IncreaseDecreaseInOperatingLeaseLiability | USD | 1.02M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 |
| us-gaap | IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets | Increase (Decrease) in Prepaid Expense and Other Assets | USD | -4.74M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 |
| us-gaap | IncrementalCommonSharesAttributableToShareBasedPaymentArrangements | Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements | shares | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012352 |
| us-gaap | IntangibleAssetsNetExcludingGoodwill | Intangible Assets, Net (Excluding Goodwill) | USD | 14.03M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 | |
| us-gaap | InterestExpense | Interest Expense | USD | 441,000 | 2024-01-01 | 2024-03-31 | 2024 | Q1 | 10-Q | 2024-05-08 | 0001628280-24-021723 |
| us-gaap | InterestExpenseNonoperating | InterestExpenseNonoperating | USD | 803,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 |
| us-gaap | InterestPortionOfMinimumLeasePaymentsSaleLeasebackTransactions | Interest Portion of Minimum Lease Payments, Sale Leaseback Transactions | USD | 1.30M | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-09 | 0000950170-22-023935 | |
| us-gaap | InventoryFinishedGoods | Inventory, Finished Goods, Gross | USD | 12.95M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 | |
| us-gaap | InventoryGross | Inventory, Gross | USD | 52.37M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 | |
| us-gaap | InventoryNet | Inventory, Net | USD | 52.37M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 | |
| us-gaap | InventoryRawMaterials | Inventory, Raw Materials, Gross | USD | 23.13M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 | |
| us-gaap | InventoryWorkInProcess | Inventory, Work in Process, Gross | USD | 16.29M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 | |
| us-gaap | InventoryWriteDown | Inventory Write-down | USD | 831,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 |
| us-gaap | InvestmentIncomeInterest | Investment Income, Interest | USD | 2.63M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 |
| us-gaap | LeaseAndRentalExpense | Operating Leases, Rent Expense | USD | 2.10M | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-17 | 0000950170-22-004106 |
| us-gaap | LeaseCost | Lease, Cost | USD | 3.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDue | Lessee, Operating Lease, Liability, to be Paid | USD | 20.07M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive | Lessee, Operating Lease, Liability, to be Paid, after Year Five | USD | 7.13M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012352 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths | Lessee, Operating Lease, Liability, to be Paid, Year One | USD | 4.24M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFive | Lessee, Operating Lease, Liability, to be Paid, Year Five | USD | 1.40M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012352 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFour | Lessee, Operating Lease, Liability, to be Paid, Year Four | USD | 1.64M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearThree | Lessee, Operating Lease, Liability, to be Paid, Year Three | USD | 2.13M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearTwo | Lessee, Operating Lease, Liability, to be Paid, Year Two | USD | 3.80M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear | Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year | USD | 990,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 | |
| us-gaap | LesseeOperatingLeaseLiabilityUndiscountedExcessAmount | Lessee, Operating Lease, Liability, Undiscounted Excess Amount | USD | 3.84M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 | |
| us-gaap | LessorOperatingLeasePaymentsToBeReceived | Lessor, Operating Lease, Payments to be Received | USD | 16.48M | 2022-12-31 | 2022 | FY | 10-K | 2023-03-01 | 0000950170-23-005610 | |
| us-gaap | LessorOperatingLeasePaymentsToBeReceivedAfterRollingYearFive | Lessor, Operating Lease, Payments to be Received, after Rolling Year Five | USD | 4.57M | 2022-12-31 | 2022 | FY | 10-K | 2023-03-01 | 0000950170-23-005610 | |
| us-gaap | LessorOperatingLeasePaymentsToBeReceivedNextRollingTwelveMonths | Lessor, Operating Lease, Payments to be Received, Next Rolling Twelve Months | USD | 2.25M | 2022-12-31 | 2022 | FY | 10-K | 2023-03-01 | 0000950170-23-005610 | |
| us-gaap | LessorOperatingLeasePaymentsToBeReceivedRollingYearFive | Lessor, Operating Lease, Payments to be Received, Rolling Year Five | USD | 2.22M | 2022-12-31 | 2022 | FY | 10-K | 2023-03-01 | 0000950170-23-005610 | |
| us-gaap | LessorOperatingLeasePaymentsToBeReceivedRollingYearFour | Lessor, Operating Lease, Payments to be Received, Rolling Year Four | USD | 2.21M | 2022-12-31 | 2022 | FY | 10-K | 2023-03-01 | 0000950170-23-005610 | |
| us-gaap | LessorOperatingLeasePaymentsToBeReceivedRollingYearThree | Lessor, Operating Lease, Payments to be Received, Rolling Year Three | USD | 2.42M | 2022-12-31 | 2022 | FY | 10-K | 2023-03-01 | 0000950170-23-005610 | |
| us-gaap | LessorOperatingLeasePaymentsToBeReceivedRollingYearTwo | Lessor, Operating Lease, Payments to be Received, Rolling Year Two | USD | 2.80M | 2022-12-31 | 2022 | FY | 10-K | 2023-03-01 | 0000950170-23-005610 | |
| us-gaap | Liabilities | Liabilities | USD | 124.79M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 | |
| us-gaap | LiabilitiesAndStockholdersEquity | Liabilities and Equity | USD | 446.14M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 | |
| us-gaap | LiabilitiesCurrent | Liabilities, Current | USD | 84.95M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 | |
| us-gaap | LitigationReserveNoncurrent | Estimated Litigation Liability, Noncurrent | USD | 5.88M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 | |
| us-gaap | LitigationSettlementInterest | Litigation Settlement Interest | USD | 600,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 |
| us-gaap | LongTermConstructionLoanCurrent | Long-term Construction Loan, Current | USD | 8.35M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 | |
| us-gaap | MarketableSecurities | Marketable Securities | USD | 189.09M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 | |
| us-gaap | MarketableSecuritiesUnrealizedGainLoss | Marketable Securities, Unrealized Gain (Loss) | USD | -509,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 |
| us-gaap | MarketingAndAdvertisingExpense | Marketing and Advertising Expense | USD | 3.30M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 |
| us-gaap | MinimumLeasePaymentsSaleLeasebackTransactions | Minimum Lease Payments, Sale Leaseback Transactions | USD | 17.04M | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-09 | 0000950170-22-023935 | |
| us-gaap | MinimumLeasePaymentsSaleLeasebackTransactionsThereafter | Minimum Lease Payments, Sale Leaseback Transactions, Thereafter | USD | 4.71M | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-09 | 0000950170-22-023935 | |
| us-gaap | MinimumLeasePaymentsSaleLeasebackTransactionsWithinFiveYears | Minimum Lease Payments, Sale Leaseback Transactions, within Five Years | USD | 2.58M | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-09 | 0000950170-22-023935 | |
| us-gaap | MinimumLeasePaymentsSaleLeasebackTransactionsWithinFourYears | Minimum Lease Payments, Sale Leaseback Transactions, within Four Years | USD | 2.60M | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-09 | 0000950170-22-023935 | |
| us-gaap | MinimumLeasePaymentsSaleLeasebackTransactionsWithinOneYear | Minimum Lease Payments, Sale Leaseback Transactions, Next Twelve Months | USD | 805,000 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-09 | 0000950170-22-023935 | |
| us-gaap | MinimumLeasePaymentsSaleLeasebackTransactionsWithinThreeYears | Minimum Lease Payments, Sale Leaseback Transactions, within Three Years | USD | 2.99M | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-09 | 0000950170-22-023935 | |
| us-gaap | MinimumLeasePaymentsSaleLeasebackTransactionsWithinTwoYears | Minimum Lease Payments, Sale Leaseback Transactions, within Two Years | USD | 3.35M | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-09 | 0000950170-22-023935 | |
| us-gaap | MoneyMarketFundsAtCarryingValue | Money Market Funds, at Carrying Value | USD | 40.90M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 | |
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | 2.61M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 |
| us-gaap | NetCashProvidedByUsedInInvestingActivities | Net Cash Provided by (Used in) Investing Activities | USD | -21.86M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | -5.82M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | -37.12M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 |
| us-gaap | NetIncomeLossAttributableToNoncontrollingInterest | Net Income (Loss) Attributable to Noncontrolling Interest | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012352 |
| us-gaap | NetIncomeLossAvailableToCommonStockholdersBasic | Net Income (Loss) Available to Common Stockholders, Basic | USD | -37.12M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 |
| us-gaap | NetIncomeLossAvailableToCommonStockholdersDiluted | Net Income (Loss) Available to Common Stockholders, Diluted | USD | -37.12M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 |
| us-gaap | NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsNonredeemable | Noncontrolling Interest in Net Income (Loss) Other Noncontrolling Interests, Nonredeemable | USD | -92,000 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-01 | 0000950170-23-005610 |
| us-gaap | NoncurrentAssets | Long-Lived Assets | USD | 20.61M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 | |
| us-gaap | NonoperatingIncomeExpense | Nonoperating Income (Expense) | USD | 2.36M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 |
| us-gaap | NumberOfOperatingSegments | Number of Operating Segments | segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 |
| us-gaap | NumberOfReportableSegments | Number of Reportable Segments | segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 |
| us-gaap | OperatingExpenses | Operating Expenses | USD | 119.09M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 |
| us-gaap | OperatingIncomeLoss | Operating Income (Loss) | USD | -38.29M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 |
| us-gaap | OperatingLeaseCost | Operating Lease, Cost | USD | 2.92M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 |
| us-gaap | OperatingLeaseLiability | Operating Lease, Liability | USD | 16.23M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 | |
| us-gaap | OperatingLeaseLiabilityCurrent | Operating Lease, Liability, Current | USD | 3.46M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 | |
| us-gaap | OperatingLeaseLiabilityNoncurrent | Operating Lease, Liability, Noncurrent | USD | 12.78M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 | |
| us-gaap | OperatingLeaseRightOfUseAsset | Operating Lease, Right-of-Use Asset | USD | 10.33M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 | |
| us-gaap | OperatingLeaseRightOfUseAssetAmortizationExpense | Operating Lease, Right-of-Use Asset, Amortization Expense | USD | 2.92M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 |
| us-gaap | OperatingLeasesRentExpenseSubleaseRentals1 | Operating Leases, Rent Expense, Sublease Rentals | USD | 600,000 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-17 | 0000950170-22-004106 |
| us-gaap | OperatingLeaseWeightedAverageDiscountRatePercent | Operating Lease, Weighted Average Discount Rate, Percent | pure | 0.047 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 | |
| us-gaap | OtherAccruedLiabilitiesCurrent | Other Accrued Liabilities, Current | USD | 1.30M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 | |
| us-gaap | OtherAssetsCurrent | Other Assets, Current | USD | 2.69M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 | |
| us-gaap | OtherAssetsNoncurrent | Other Assets, Noncurrent | USD | 5.55M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 | |
| us-gaap | OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax | Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax | USD | 906,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 |
| us-gaap | OtherComprehensiveIncomeLossTaxPortionAttributableToParent1 | Other Comprehensive Income (Loss), Tax, Portion Attributable to Parent | USD | -11.20M | 2023-01-01 | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-08 | 0000950170-23-039899 |
| us-gaap | OtherLiabilitiesCurrent | Other Liabilities, Current | USD | 20.21M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 | |
| us-gaap | OtherLiabilitiesNoncurrent | Other Liabilities, Noncurrent | USD | 2.33M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 | |
| us-gaap | OtherNoncashIncomeExpense | Other Noncash Income (Expense) | USD | -1.83M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 |
| us-gaap | OtherNonoperatingIncomeExpense | Other Nonoperating Income (Expense) | USD | 535,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 |
| us-gaap | OtherPrepaidExpenseCurrent | Other Prepaid Expense, Current | USD | 2.18M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 | |
| us-gaap | OtherReceivables | Other Receivables | USD | 1.59M | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-12 | 0000950170-22-009425 | |
| us-gaap | PaymentsForRepurchaseOfCommonStock | Payments for Repurchase of Common Stock | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 |
| us-gaap | PaymentsForRepurchaseOfEquity | Payments for Repurchase of Equity | USD | 14.62M | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-07 | 0001628280-24-045834 |
| us-gaap | PaymentsForRepurchaseOfInitialPublicOffering | Payments for Repurchase of Initial Public Offering | USD | 0 | 2022-01-01 | 2022-06-30 | 2022 | Q2 | 10-Q | 2022-08-10 | 0000950170-22-016500 |
| us-gaap | PaymentsOfStockIssuanceCosts | Payments of Stock Issuance Costs | USD | 334,000 | 2020-01-01 | 2020-12-31 | 2022 | FY | 10-K | 2023-03-01 | 0000950170-23-005610 |
| us-gaap | PaymentsToAcquireBusinessesGross | Payments to Acquire Businesses, Gross | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012352 |
| us-gaap | PaymentsToAcquireIntangibleAssets | Payments to Acquire Intangible Assets | USD | 103,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 |
| us-gaap | PaymentsToAcquirePropertyPlantAndEquipment | Payments to Acquire Property, Plant, and Equipment | USD | 5.89M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 |
| us-gaap | PaymentsToAcquireRealEstateHeldForInvestment | Payments to Acquire Real Estate Held-for-investment | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-28 | 0001628280-25-008780 |
| us-gaap | PrepaidExpenseAndOtherAssetsCurrent | Prepaid Expense and Other Assets, Current | USD | 11.09M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 | |
| us-gaap | PrepaidInsurance | Prepaid Insurance | USD | 730,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 | |
| us-gaap | PrepaidRent | Prepaid Rent | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012352 | |
| us-gaap | PrepaidTaxes | Prepaid Taxes | USD | 2.79M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 | |
| us-gaap | PresentValueOfFutureMinimumLeasePaymentsSaleLeasebackTransactions | Present Value of Future Minimum Lease Payments, Sale Leaseback Transactions | USD | 15.74M | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-09 | 0000950170-22-023935 | |
| us-gaap | ProceedsFromIncomeTaxRefunds | Proceeds from Income Tax Refunds | USD | 180,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 |
| us-gaap | ProceedsFromIssuanceInitialPublicOffering | Proceeds from Issuance Initial Public Offering | USD | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-13 | 0001628280-24-010933 |
| us-gaap | ProceedsFromIssuanceOfDebt | Proceeds from Issuance of Debt | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-28 | 0001628280-25-008780 |
| us-gaap | ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock | Proceeds from Issuance of Redeemable Convertible Preferred Stock | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-01 | 0000950170-23-005610 |
| us-gaap | ProceedsFromLinesOfCredit | Proceeds from Lines of Credit | USD | 6.17M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 |
| us-gaap | ProceedsFromLoanOriginations1 | Proceeds from Loan Originations | USD | 4.10M | 2020-05-07 | 2022 | FY | 10-K | 2023-03-01 | 0000950170-23-005610 | |
| us-gaap | ProceedsFromSaleAndMaturityOfMarketableSecurities | Proceeds from Sale and Maturity of Marketable Securities | USD | 194.59M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 |
| us-gaap | ProceedsFromSaleOfPropertyPlantAndEquipment | Proceeds from Sale of Property, Plant, and Equipment | USD | 80,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 |
| us-gaap | ProceedsFromStockOptionsExercised | Proceeds from Stock Options Exercised | USD | 1.12M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 |
| us-gaap | ProceedsFromStockPlans | Proceeds from Stock Plans | USD | 851,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 |
| us-gaap | ProductWarrantyAccrualClassifiedCurrent | Product Warranty Accrual, Current | USD | 1.41M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 | |
| us-gaap | ProductWarrantyExpense | Product Warranty Expense | USD | 961,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 |
| us-gaap | ProfitLoss | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | USD | -66.54M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-28 | 0001140361-26-017479 | ||
| us-gaap | PropertyPlantAndEquipmentGross | Property, Plant and Equipment, Gross | USD | 35.98M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 | |
| us-gaap | PropertyPlantAndEquipmentNet | Property, Plant and Equipment, Net | USD | 20.61M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 | |
| us-gaap | ProvisionForDoubtfulAccounts | Accounts Receivable, Credit Loss Expense (Reversal) | USD | 851,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 |
| us-gaap | ProvisionForLoanLossesExpensed | Financing Receivable, Credit Loss, Expense (Reversal) | USD | 830,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 |
| us-gaap | ProvisionForOtherCreditLosses | Provision for Other Credit Losses | USD | 447,000 | 2026-01-01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-07 | 0001628280-26-032293 |
| us-gaap | PurchaseObligation | Purchase Obligation | USD | 1.95M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 | |
| us-gaap | PurchaseObligationDueInNextTwelveMonths | Purchase Obligation, to be Paid, Year One | USD | 1.45M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 | |
| us-gaap | PurchaseObligationDueInSecondYear | Purchase Obligation, to be Paid, Year Two | USD | 110,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 | |
| us-gaap | PurchaseObligationDueInThirdYear | Purchase Obligation, to be Paid, Year Three | USD | 48,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012352 | |
| us-gaap | PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear | Purchase Obligation, to be Paid, Remainder of Fiscal Year | USD | 376,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 | |
| us-gaap | RepaymentsOfDebt | Repayments of Debt | USD | 4.85M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 |
| us-gaap | ResearchAndDevelopmentExpense | Research and Development Expense | USD | 28.70M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 |
| us-gaap | RestrictedCash | Restricted Cash | USD | 0 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-05 | 0001628280-26-053496 | |
| us-gaap | RestrictedCashCurrent | Restricted Cash, Current | USD | 385,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 | |
| us-gaap | RestrictedCashEquivalents | Restricted Cash Equivalents | USD | 300,000 | 2023-09-30 | 2024 | Q3 | 10-Q | 2024-11-07 | 0001628280-24-045834 | |
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | -138.86M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 | |
| us-gaap | RevenueFromContractWithCustomerExcludingAssessedTax | Revenue from Contract with Customer, Excluding Assessed Tax | USD | 145.50M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 |
| us-gaap | RevenueRemainingPerformanceObligation | Revenue, Remaining Performance Obligation, Amount | USD | 49.02M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 | |
| us-gaap | Revenues | Revenues | USD | 142.98M | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-07 | 0001628280-24-045834 |
| us-gaap | RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability | USD | 1.27M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 |
| us-gaap | SalesAndExciseTaxPayableCurrent | Sales and Excise Tax Payable, Current | USD | 3.69M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 | |
| us-gaap | SalesAndExciseTaxPayableCurrentAndNoncurrent | Sales and Excise Tax Payable | USD | 100,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012352 | |
| us-gaap | SellingAndMarketingExpense | Selling and Marketing Expense | USD | 36.73M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 |
| us-gaap | SettlementLiabilitiesCurrent | Settlement Liabilities, Current | USD | 2.43M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 | |
| us-gaap | ShareBasedCompensation | Share-based Payment Arrangement, Noncash Expense | USD | 15.05M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period | shares | 0 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-17 | 0000950170-22-004106 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value | USD/shares | 0 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-17 | 0000950170-22-004106 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period | shares | 0 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-17 | 0000950170-22-004106 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value | USD/shares | 0 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-17 | 0000950170-22-004106 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate | pure | 0.901 | 2021-01-01 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-12 | 0000950170-21-004256 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate | pure | 0.01 | 2021-01-01 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-12 | 0000950170-21-004256 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value | USD | 7.13M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number | shares | 6.32M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price | USD/shares | 8.82 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period | shares | 881,270 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | shares | 1.72M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value | USD/shares | 2.69 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | USD | 11.05M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | shares | 9.20M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | USD/shares | 7.58 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value | USD | 74.99M | 2021-12-31 | 2021 | FY | 10-K | 2022-03-17 | 0000950170-22-004106 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number | shares | 5.62M | 2021-12-31 | 2021 | FY | 10-K | 2022-03-17 | 0000950170-22-004106 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price | USD/shares | 9.96 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-17 | 0000950170-22-004106 | |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value | USD | 1.00M | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-17 | 0000950170-22-004106 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price | USD/shares | 2.74 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price | USD/shares | 11.92 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price | USD/shares | 5.06 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | USD/shares | 4.29 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 |
| us-gaap | ShortTermLeaseCost | Short-term Lease, Cost | USD | 75,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 |
| us-gaap | StandardProductWarrantyAccrual | Standard Product Warranty Accrual | USD | 1.41M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 | |
| us-gaap | StandardProductWarrantyAccrualWarrantiesIssued | Standard Product Warranty Accrual, Increase for Warranties Issued | USD | 918,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 |
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | 321.35M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 | |
| us-gaap | StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest | USD | 341.74M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012352 | |
| us-gaap | StockholdersEquityNoteStockSplitConversionRatio1 | Stockholders' Equity Note, Stock Split, Conversion Ratio | pure | 1.333 | 2021-07-16 | 2023 | Q3 | 10-Q | 2023-11-14 | 0001628280-23-038974 | |
| us-gaap | StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans | Stock Issued During Period, Shares, Employee Stock Purchase Plans | shares | 296,236 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-13 | 0001628280-24-010933 |
| us-gaap | StockIssuedDuringPeriodSharesStockOptionsExercised | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | shares | 407,670 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 |
| us-gaap | StockIssuedDuringPeriodValueEmployeeBenefitPlan | Stock Issued During Period, Value, Employee Benefit Plan | USD | 1.15M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012352 |
| us-gaap | StockIssuedDuringPeriodValueEmployeeStockPurchasePlan | Stock Issued During Period, Value, Employee Stock Purchase Plan | USD | 1.01M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 |
| us-gaap | StockIssuedDuringPeriodValueStockOptionsExercised | Stock Issued During Period, Value, Stock Options Exercised | USD | 644,000 | 2021-01-01 | 2021-12-31 | 2023 | FY | 10-K | 2024-03-13 | 0001628280-24-010933 |
| us-gaap | StockRepurchasedAndRetiredDuringPeriodValue | Stock Repurchased and Retired During Period, Value | USD | -29,000 | 2025-07-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 |
| us-gaap | StockRepurchasedDuringPeriodShares | Stock Repurchased During Period, Shares | shares | 13.88M | 2023-05-17 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012352 |
| us-gaap | StockRepurchasedDuringPeriodValue | Stock Repurchased During Period, Value | USD | 21.61M | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-28 | 0001628280-25-008780 |
| us-gaap | StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1 | Stock Repurchase Program, Remaining Authorized Repurchase Amount | USD | 35.00M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012352 | |
| us-gaap | SubleaseIncome | Sublease Income | USD | 57,000 | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-07 | 0001628280-24-045834 |
| us-gaap | TemporaryEquityForeignCurrencyTranslationAdjustments | Temporary Equity, Foreign Currency Translation Adjustments | USD | 61,000 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 |
| us-gaap | TenantImprovements | Tenant Improvements | USD | 575,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 | |
| us-gaap | TreasuryStockAcquiredAverageCostPerShare | Treasury Stock Acquired, Average Cost Per Share | USD/shares | 5.8 | 2023-05-17 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012352 |
| us-gaap | UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic | Undistributed Earnings (Loss) Allocated to Participating Securities, Basic | USD | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-13 | 0001628280-24-010933 |
| us-gaap | UnrecognizedTaxBenefits | Unrecognized Tax Benefits | USD | 3.53M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012352 | |
| us-gaap | UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions | Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions | USD | 53,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012352 |
| us-gaap | UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities | Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities | USD | 637,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012352 |
| us-gaap | UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions | Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions | USD | 513,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012352 |
| us-gaap | UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions | Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions | USD | 217,000 | 2023-01-01 | 2023-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012352 |
| us-gaap | UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate | Unrecognized Tax Benefits that Would Impact Effective Tax Rate | USD | 3.10M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012352 | |
| us-gaap | USGovernmentAgenciesSecuritiesAtCarryingValue | US Government Agencies Securities, at Carrying Value | USD | 0 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-13 | 0001628280-24-010933 | |
| us-gaap | USGovernmentSecuritiesAtCarryingValue | US Government Securities, at Carrying Value | USD | 1.99M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 | |
| us-gaap | VariableInterestEntityOwnershipPercentage | Variable Interest Entity, Qualitative or Quantitative Information, Ownership Percentage | pure | 0.5 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 |
| us-gaap | WeightedAverageNumberOfDilutedSharesOutstanding | Weighted Average Number of Shares Outstanding, Diluted | shares | 129.51M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 |
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasic | Weighted Average Number of Shares Outstanding, Basic | shares | 129.51M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070259 |